Suppr超能文献

德国的研究表明,接种 SARS-CoV-2 疫苗后静脉血栓栓塞或肺栓塞的发生率没有增加。

No increased incidence of venous thrombosis or pulmonary embolism after SARS-CoV-2 vaccination in Germany.

机构信息

Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling, Siegen, Germany.

Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling, Siegen, Germany.

出版信息

Public Health. 2022 Jun;207:14-18. doi: 10.1016/j.puhe.2022.03.004. Epub 2022 Mar 16.

Abstract

OBJECTIVES

Vaccination is one of the most effective measures to combat the COVID-19 pandemic. The main reason for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination hesitancy is the potential side-effects. This study aimed to investigate the incidence of venous thrombosis and pulmonary embolism in patients who received SARS-CoV-2 vaccination.

STUDY DESIGN

This was a retrospective cohort study.

METHODS

Individuals aged ≥18 years who received an initial vaccination for COVID-19 in one of 1134 general practices in Germany between April and June 2021 were included in the study. Vaccinated patients were matched to unvaccinated individuals by age, sex, index month (April to June 2020 [unvaccinated cohort] or April to June 2021 [vaccinated cohort]) and diagnoses that may be associated with an increased incidence of thrombosis documented within 12 months before the index date. The incidences of thrombosis and non-fatal pulmonary embolism as a function of COVID-19 vaccination were analysed.

RESULTS

The present study included 326,833 individuals who were vaccinated against COVID-19 and 326,833 matched unvaccinated individuals. During the follow-up period, 406 vaccinated patients and 342 individuals in the control group received a diagnosis of thrombosis or non-fatal pulmonary embolism. This resulted in an incidence rate of 11.9 vs 11.3 cases per 1000 patient-years for vaccinated vs unvaccinated individuals, respectively, and a non-significant overall incidence rate ratio (IRR: 1.06; 95% confidence interval [CI]: 0.93-1.22). The highest IRR was observed in the 41-60 years age group (IRR: 1.30; 95% CI: 0.98-1.73), and the lowest IRR was seen in the 18-40 years age group (IRR: 0.6; 95% CI: 0.0-1.05); however, none of the individual age group incidence rates was significant.

CONCLUSIONS

The results indicate that the occurrence of thrombosis or pulmonary embolism after COVID-19 vaccination is a coincidental finding rather than a consequence of vaccination.

摘要

目的

接种疫苗是应对 COVID-19 大流行的最有效措施之一。严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫苗接种犹豫的主要原因是潜在的副作用。本研究旨在调查接种 SARS-CoV-2 疫苗的患者中静脉血栓形成和肺栓塞的发生率。

研究设计

这是一项回顾性队列研究。

方法

本研究纳入了 2021 年 4 月至 6 月期间在德国 1134 家普通诊所中接受 COVID-19 初始疫苗接种的年龄≥18 岁的个体。接种疫苗的患者通过年龄、性别、索引月份(2020 年 4 月至 6 月[未接种组]或 2021 年 4 月至 6 月[接种组])和在索引日期前 12 个月内记录的可能与血栓形成发生率增加相关的诊断与未接种个体进行匹配。分析 COVID-19 疫苗接种与血栓形成和非致命性肺栓塞的关系。

结果

本研究纳入了 326833 名接种 COVID-19 疫苗的个体和 326833 名匹配的未接种个体。在随访期间,406 名接种疫苗的患者和 342 名对照组患者被诊断为血栓形成或非致命性肺栓塞。因此,接种疫苗组和未接种疫苗组的患者中每 1000 人年的发病率分别为 11.9 例和 11.3 例,总体发病率比值比(IRR)无显著差异(1.06;95%置信区间[CI]:0.93-1.22)。在 41-60 岁年龄组中观察到的 IRR 最高(IRR:1.30;95% CI:0.98-1.73),在 18-40 岁年龄组中观察到的 IRR 最低(IRR:0.6;95% CI:0.0-1.05);然而,各年龄组的发病率均无统计学意义。

结论

研究结果表明,COVID-19 疫苗接种后发生血栓形成或肺栓塞是偶发事件,而不是疫苗接种的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb28/8923878/a09f26fba258/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验